Vimarsana
Biggest News Aggregation in the World

Page 25 - Cell Proliferation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Proliferation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Proliferation Today - Breaking & Trending Today

Asher Biotherapeutics Contracts ProBioGen to Develop and Manufacture Their Lead Candidate - Vimarsana News

Asher Biotherapeutics Contracts ProBioGen to Develop and Manufacture Their Lead Candidate

Asher Biotherapeutics Contracts ProBioGen to Develop and Manufacture Their Lead Candidate   BERLIN, Germany, April 26, 2021 / B3C newswire / --ProBioGen AG today announced that Asher Biotherapeutics, Inc., has entered into a service agreement covering all aspects of cell line development, process development and GMP manufacturing at 1000 L bioreactor scale. ProBioGen will now advance the development of Asher's lead candidate in immuno-oncology applying its unique transposase technology DirectedLuck™ which greatly accelerates time-to-clinic. Asher Biotherapeutics, a ...

Scientists decode activation mechanism of SHP2 protein that can trigger cancer - Vimarsana News

Scientists decode activation mechanism of SHP2 protein that can trigger cancer

Scientists decode activation mechanism of SHP2 protein that can trigger cancer There are many different types of cancer, but they all have one thing in common: errors in the signals that control normal cell behavior can cause uncontrolled cell growth and cell division, leading to a tumor. An enzyme called SHP2 plays a key role in this regard. SHP2 is a signaling molecule that in its activated state stimulates cell proliferation. In a normal healthy body, the rates of cell proliferation and cell death are balanced and tumors do not develop. However, if SHP2 becomes too active, the number of ce...

POT1 gene linked to glioma development mediates its effects in a sex-specific manner - Vimarsana News

POT1 gene linked to glioma development mediates its effects in a sex-specific manner

POT1 gene linked to glioma development mediates its effects in a sex-specific manner Researchers at Baylor College of Medicine and collaborators at other institutions have discovered that POT1, a gene known to be associated with risk of glioma, the most common type of malignant brain tumor, mediates its effects in a sex-specific manner. Researchers found that female mice with glioma that lacked the gene survived less than males. This led them to investigate human glioma cells, where they found that low POT1 expression correlated with reduced survival in females. Published in the journal Canc...

Researchers develop an effective strategy to fight against chronic myelomonocytic leukemia - Vimarsana News

Researchers develop an effective strategy to fight against chronic myelomonocytic leukemia

Researchers develop an effective strategy to fight against chronic myelomonocytic leukemia Leukemias are debilitating cancers of the hematopoietic or blood-forming cells of the bone marrow. Now, researchers at Tokyo Medical and Dental University (TMDU) describe an ingenious strategy against chronic myelomonocytic leukemia (CMML) wherein an antibody-drug conjugate (ADC) comprising a cytotoxic drug payload linked to an antibody that selectively targets specific cell lines effectively blocks malignant cell proliferation at source. Hematopoietic stem and progenitor cells (HSPCs) continually diffe...

Is non-severe SARS-CoV-2 infection characterized by early T cell proliferation? - Vimarsana News

Is non-severe SARS-CoV-2 infection characterized by early T cell proliferation?

Is non-severe SARS-CoV-2 infection characterized by early T cell proliferation? The extent of severity of the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), varies from asymptomatic, mild to severe. Scientists found that during the first wave of the pandemic, individuals infected with non-severe SARS-CoV-2, before the onset of the vaccination program, induced effective host-defense mechanisms in naive populations. To date, little evidence has been documented regarding the immune responses after the onset of the symptoms or virus de...